SEC Form 4 · accession 0001209191-16-125986
NANOPHASE TECHNOLOGIES Corp · NANX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Janet Whitmore
Director
Period of report
Jun 6, 2016
Accepted (ET)
Jun 6, 2016 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883107
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 6, 2016 | P | 6,794 | $0.519 | A | 1,081,165 | D | |
| Common Stock | holding | — | — | — | 32,675 | I | By Daughter |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.36 | holding | — | — | — | Jan 31, 2012 | Jan 31, 2021 | Common Stock | 10,000 | 10,000 | D |
| Deferred Common StockF2,F3,F4 | — | holding | — | — | — | — | — | Common Stock | 2,000 | 20,030 | D |
| Stock Appreciation RightF5 | $0.99 | holding | — | — | — | — | — | Common Stock | 2,000 | 14,000 | D |
| Stock Option (right to buy)F1 | $0.30 | holding | — | — | — | Aug 7, 2013 | Aug 7, 2022 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (right to buy)F1 | $0.415 | holding | — | — | — | Feb 14, 2014 | Feb 14, 2023 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (right to buy)F6 | $0.52 | holding | — | — | — | Feb 13, 2015 | Feb 13, 2024 | Common Stock | 10,000 | 10,000 | D |
| Stock Option (right to buy)F1 | $0.44 | holding | — | — | — | Feb 18, 2016 | Feb 18, 2025 | Common Stock | 9,000 | 9,000 | D |
| Stock Option (right to buy)F1 | $0.42 | holding | — | — | — | Feb 23, 2017 | Feb 23, 2026 | Common Stock | 8,100 | 8,100 | D |
Explanation of responses
- F1Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
- F2Each share of deferred common stock represents a right to receive one share of common stock.
- F3The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
- F4Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
- F5The stock appreciation right becomes payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99.
- F6Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.